|
HU222249B1
(hu)
*
|
1991-03-08 |
2003-05-28 |
Amylin Pharmaceuticals Inc. |
Eljárás amilin agonista peptidszármazékok és ezeket tartalmazó gyógyszerkészítmények előállítására
|
|
DE69426304T2
(de)
*
|
1993-09-07 |
2001-03-15 |
Amylin Pharmaceuticals, Inc. |
Methoden zur regulation der den magen und darm betreffenden motilitaet
|
|
US6143718A
(en)
*
|
1995-06-07 |
2000-11-07 |
Amylin Pharmaceuticals, Inc. |
Treatment of Type II diabetes mellutis with amylin agonists
|
|
US7312196B2
(en)
|
1997-01-08 |
2007-12-25 |
Amylin Pharmaceuticals, Inc. |
Formulations for amylin agonist peptides
|
|
US6410511B2
(en)
|
1997-01-08 |
2002-06-25 |
Amylin Pharmaceuticals, Inc. |
Formulations for amylin agonist peptides
|
|
US7101853B2
(en)
*
|
1997-05-06 |
2006-09-05 |
Amylin Pharmaceuticals, Inc. |
Method for treating or preventing gastritis using amylin or amylin agonists
|
|
US7910548B2
(en)
*
|
1997-06-06 |
2011-03-22 |
Amylin Pharmaceuticals, Inc. |
Methods for treating obesity
|
|
JP4353544B2
(ja)
*
|
1998-01-09 |
2009-10-28 |
アミリン・ファーマシューティカルズ，インコーポレイテッド |
アミリン作動薬ペプチド用製剤
|
|
US6087334A
(en)
*
|
1998-08-21 |
2000-07-11 |
Amylin Pharmaceuticals, Inc. |
Anti-diabetic peptides
|
|
WO2003057244A2
(en)
*
|
2002-01-08 |
2003-07-17 |
Amylin Pharmaceuticals, Inc. |
Use of amylin agonists to modulate triglycerides
|
|
PL374860A1
(en)
*
|
2002-07-09 |
2005-11-14 |
Bristol-Myers Squibb Company |
Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method
|
|
CA2525168A1
(en)
*
|
2003-05-14 |
2004-12-02 |
Emisphere Technologies, Inc. |
Compositions for delivering peptide yy and pyy agonists
|
|
EP1644027B1
(en)
*
|
2003-07-16 |
2014-04-09 |
Evotec International GmbH |
Use of pleiotrophin for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome
|
|
JP2008500281A
(ja)
*
|
2004-02-11 |
2008-01-10 |
アミリン・ファーマシューティカルズ，インコーポレイテッド |
アミリンファミリーペプチドおよびそれらを作成し使用するための方法
|
|
BRPI0506793A
(pt)
*
|
2004-02-20 |
2007-05-22 |
Rinat Neuroscience Corp |
métodos de tratamento de obesidade ou diabetes com o uso de nt-4/5
|
|
US7399744B2
(en)
*
|
2004-03-04 |
2008-07-15 |
Amylin Pharmaceuticals, Inc. |
Methods for affecting body composition
|
|
CN101193626A
(zh)
*
|
2005-03-11 |
2008-06-04 |
益德威士医药股份有限公司 |
奥曲肽的受控释放制剂
|
|
US7759312B2
(en)
*
|
2005-03-11 |
2010-07-20 |
Endo Pharmaceuticals Solutions Inc. |
Delivery of dry formulations of octreotide
|
|
CA2637707A1
(en)
*
|
2006-02-02 |
2007-08-09 |
Rinat Neuroscience Corporation |
Methods for treating obesity by administering a trkb antagonist
|
|
CN101400367A
(zh)
*
|
2006-02-02 |
2009-04-01 |
瑞纳神经科学公司 |
施用trkb激动剂治疗不希望的重量减轻或进食障碍的方法
|
|
US20100086997A1
(en)
*
|
2006-12-20 |
2010-04-08 |
Rinat Enuroscience Corp |
TrkB Agonists for Treating Autoimmune Disorders
|
|
BRPI0722276A2
(pt)
*
|
2007-11-14 |
2014-04-22 |
Amylin Pharmaceuticals Inc |
Métodos para tratar obesidade e doenças e distúrbios relacionados à obesidade
|
|
JP5622725B2
(ja)
*
|
2008-06-25 |
2014-11-12 |
エンド ファーマスーティカルズ ソリューションズ インコーポレイテッド．Ｅｎｄｏ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｓｏｌｕｔｉｏｎｓｉｎｃ． |
エキセナチド及び他のポリペプチド類の持続的送達
|
|
KR20110025974A
(ko)
*
|
2008-06-25 |
2011-03-14 |
엔도 파마슈티컬즈, 솔루션스 아이엔씨. |
이형제를 함유하는 옥트레오티드 이식물
|
|
HUE068164T2
(hu)
|
2008-10-17 |
2024-12-28 |
Sanofi Aventis Deutschland |
Egy inzulin és egy GLP-1 agonista kombinációja
|
|
JP2009149684A
(ja)
*
|
2009-03-11 |
2009-07-09 |
Amylin Pharmaceut Inc |
アミリン作動薬ペプチド用製剤
|
|
JP5993147B2
(ja)
*
|
2009-03-12 |
2016-09-14 |
キーバイオサイエンス・アクチエンゲゼルシャフト |
糖尿病およびメタボリックシンドロームの治療
|
|
US20110118178A1
(en)
*
|
2009-11-13 |
2011-05-19 |
Sanofi-Aventis Deutschland Gmbh |
Method of treatment of diabetes type 2 comprising add-on therapy to insulin glargine and metformin
|
|
SG10201500871TA
(en)
|
2009-11-13 |
2015-04-29 |
Sanofi Aventis Deutschland |
Pharmaceutical composition comprising a glp-1 agonist and methionine
|
|
US20110118180A1
(en)
*
|
2009-11-13 |
2011-05-19 |
Sanofi-Aventis Deutschland Gmbh |
Method of treatment of diabetes type 2 comprising add-on therapy to metformin
|
|
CA2780460C
(en)
|
2009-11-13 |
2018-09-04 |
Sanofi-Aventis Deutschland Gmbh |
Pharmaceutical composition comprising a glp-1 agonist, an insulin and methionine
|
|
RS55378B1
(sr)
|
2010-08-30 |
2017-03-31 |
Sanofi Aventis Deutschland |
Upotreba ave0010 za proizvodnju leka za tretman diabetes mellitus tipa 2
|
|
US9821032B2
(en)
|
2011-05-13 |
2017-11-21 |
Sanofi-Aventis Deutschland Gmbh |
Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
|
|
BR112014004726A2
(pt)
|
2011-08-29 |
2017-04-04 |
Sanofi Aventis Deutschland |
combinação farmacêutica para uso no controle glicêmico em pacientes de diabetes tipo 2
|
|
TWI559929B
(en)
|
2011-09-01 |
2016-12-01 |
Sanofi Aventis Deutschland |
Pharmaceutical composition for use in the treatment of a neurodegenerative disease
|
|
BR102013017626A2
(pt)
*
|
2013-06-14 |
2015-02-10 |
Univ Rio De Janeiro |
Bioconjugados não aglomerantes de amilinomiméticos com polietilenoglicol, uso de bioconjugados não aglomerantes de amilinomiméticos com polietilenoglicol, composições farmacêuticas de baixa toxicidade, adjuvante para a prevenção ou tratamento das doenças, medicamento, método de tratamento ou prevenção de doenças.
|
|
CN106687474A
(zh)
*
|
2014-09-04 |
2017-05-17 |
诺和诺德股份有限公司 |
新型胰淀素和降钙素受体激动剂
|
|
TWI758239B
(zh)
|
2014-12-12 |
2022-03-21 |
德商賽諾菲阿凡提斯德意志有限公司 |
甘精胰島素/利司那肽固定比率配製劑
|
|
TWI748945B
(zh)
|
2015-03-13 |
2021-12-11 |
德商賽諾菲阿凡提斯德意志有限公司 |
第２型糖尿病病患治療
|
|
TW201705975A
(zh)
|
2015-03-18 |
2017-02-16 |
賽諾菲阿凡提斯德意志有限公司 |
第２型糖尿病病患之治療
|